Company Profile | April 7, 2000

CDC Technologies, Inc.

Source: CDC Technologies, Inc.
CDC Technologies, Inc. (CDC) is a recognized leader in the development and introduction of state-of-the-art diagnostic systems designed for point of care medicine. Simply stated, our mission is: to provide analyzers and reagent systems of such exceptional quality, value, and ease-of-use that professionals will in turn be able to provide better and more timely patient care, all the while enjoying a more efficient and more profitable medical practice.

In meeting this goal, CDC has developed a steady progression of cost-effective Point-of-Care systems, beginning with the MASCOTTM line of automated multispecies hematology analyzers. Introduced to the market in 1992, the MASCOT line is the first (and only) line of blood cell counters developed specifically for veterinary medicine. The line is also unique in the following ways:

  • its small sample size (only 20 microliters -- less than one drop -- of whole blood)
  • its ability to perform precise and accurate, cell-by-cell analyses
  • its ability to analyze samples from a wide variety of species
  • its easy, walk-away operation, and minimal upkeep
  • its exceptional value
Shortly after its introduction, and in response to the dynamics of the market, the MASCOT line was extended to include the HEMAVET Series. Utilizing the MASCOT patented Focused Flow TM cell-counting technologies, plus enhanced proprietary reagent systems, the HEMAVET differs in two major ways. The most obvious difference is its new, compact size. Now less than half its original dimensions, it is a welcome addition to even the smallest of lab counter spaces. It's even portable!

Perhaps more significant, however, is the variety of models and price ranges to choose from. There are currently two models available in the HEMAVET Series, offering from 16 primary parameters to as many as 27 parameters of hematology results, and priced so that a system is within the reach of every veterinary practitioner. All systems are of modular design and are fully upgradeable, so that features can be added to meet the practice's changing needs.

The HEMAVET Series clearly brings unprecedented flexibility, portability, and affordability to automated multispecies hematology.